Molina Healthcare (MOH) Cash & Equivalents (2010 - 2026)

Molina Healthcare has disclosed Cash & Equivalents across 17 years of filings, most recently posting $5.3 billion for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $5.3 billion, up 9.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.3 billion (up 9.43% YoY), and the FY2025 annual result was $4.2 billion, down 8.88% from the prior year.
• Cash & Equivalents came in at $5.3 billion for Q1 2026 at Molina Healthcare, up from $4.2 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $5.6 billion in Q3 2023 to a low of $4.0 billion in Q4 2022.
• The 5-year median for Cash & Equivalents is $4.6 billion (2023), against an average of $4.6 billion.
• Across the five-year window, Cash & Equivalents surged 31.19% in 2023 and declined 14.97% in 2024, its largest moves.
• Molina Healthcare's Cash & Equivalents stood at $4.0 billion in 2022, then gained by 21.02% to $4.8 billion in 2023, then retreated by 3.84% to $4.7 billion in 2024, then slipped by 8.88% to $4.2 billion in 2025, then increased by 25.09% to $5.3 billion in 2026.
• The last three Cash & Equivalents figures came in at $5.3 billion (Q1 2026), $4.2 billion (Q4 2025), and $4.2 billion (Q3 2025), per Business Quant data.